Shares MSCI South Korea ETF is rated a Strong Buy, driven by a structural AI memory supercycle and corporate reforms. Read ...
During the quarter, revenue growth of 7.1% was driven by 6.6% core solid waste pricing, comfortably exceeding our cost of ...
With accelerated population ageing and the growing prevalence of multimorbidity, polypharmacy in older adults has become a major challenge for medication safety and treatment effectiveness.